Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Return on Assets (2021 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Return on Assets for 4 consecutive years, with 0.59% as the latest value for Q3 2024.

  • Quarterly Return on Assets fell 55.0% to 0.59% in Q3 2024 from the year-ago period, while the trailing twelve-month figure was 0.59% through Sep 2024, down 55.0% year-over-year, with the annual reading at 0.01% for FY2023, 3.0% up from the prior year.
  • Return on Assets hit 0.59% in Q3 2024 for Pasithea Therapeutics, down from 0.39% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.01% in Q3 2022 to a low of 0.59% in Q3 2024.
  • Historically, Return on Assets has averaged 0.12% across 4 years, with a median of 0.05% in 2022.
  • Biggest five-year swings in Return on Assets: grew 3bps in 2023 and later plummeted -55bps in 2024.
  • Year by year, Return on Assets stood at 0.06% in 2021, then grew by 19bps to 0.05% in 2022, then skyrocketed by 66bps to 0.02% in 2023, then plummeted by -3602bps to 0.59% in 2024.
  • Business Quant data shows Return on Assets for KTTA at 0.59% in Q3 2024, 0.39% in Q2 2024, and 0.17% in Q1 2024.